These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 16682628)

  • 1. Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process.
    Donelan J; Boucher W; Papadopoulou N; Lytinas M; Papaliodis D; Dobner P; Theoharides TC
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7759-64. PubMed ID: 16682628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects.
    Theoharides TC; Singh LK; Boucher W; Pang X; Letourneau R; Webster E; Chrousos G
    Endocrinology; 1998 Jan; 139(1):403-13. PubMed ID: 9421440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors.
    Singh LK; Boucher W; Pang X; Letourneau R; Seretakis D; Green M; Theoharides TC
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1349-56. PubMed ID: 10027877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotensin and CRH interactions augment human mast cell activation.
    Alysandratos KD; Asadi S; Angelidou A; Zhang B; Sismanopoulos N; Yang H; Critchfield A; Theoharides TC
    PLoS One; 2012; 7(11):e48934. PubMed ID: 23155429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders.
    Singh LK; Pang X; Alexacos N; Letourneau R; Theoharides TC
    Brain Behav Immun; 1999 Sep; 13(3):225-39. PubMed ID: 10469524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute stress results in skin corticotropin-releasing hormone secretion, mast cell activation and vascular permeability, an effect mimicked by intradermal corticotropin-releasing hormone and inhibited by histamine-1 receptor antagonists.
    Lytinas M; Kempuraj D; Huang M; Boucher W; Esposito P; Theoharides TC
    Int Arch Allergy Immunol; 2003 Mar; 130(3):224-31. PubMed ID: 12660427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A neurotensin receptor antagonist inhibits acute immobilization stress-induced cardiac mast cell degranulation, a corticotropin-releasing hormone-dependent process.
    Pang X; Alexacos N; Letourneau R; Seretakis D; Gao W; Boucher W; Cochrane DE; Theoharides TC
    J Pharmacol Exp Ther; 1998 Oct; 287(1):307-14. PubMed ID: 9765351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of neurotensin, corticotropin-releasing hormone, and RFamide-related peptide-3 in E2-induced negative feedback control: studies using a mouse arcuate nucleus hypothalamic cell model.
    Tumurbaatar T; Kanasaki H; Oride A; Hara T; Okada H; Tsutsui K; Kyo S
    Biol Reprod; 2018 Dec; 99(6):1216-1226. PubMed ID: 29961889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress.
    Esposito P; Chandler N; Kandere K; Basu S; Jacobson S; Connolly R; Tutor D; Theoharides TC
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1061-6. PubMed ID: 12438528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of corticotropin-releasing hormone receptor-2 expression in human cord blood-derived cultured mast cells.
    Papadopoulou NG; Oleson L; Kempuraj D; Donelan J; Cetrulo CL; Theoharides TC
    J Mol Endocrinol; 2005 Dec; 35(3):R1-8. PubMed ID: 16326828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum neurotensin (NT) is increased in psoriasis and NT induces vascular endothelial growth factor release from human mast cells.
    Vasiadi M; Therianou A; Alysandratos KD; Katsarou-Katsari A; Petrakopoulou T; Theoharides A; Papadavid E; Stavrianeas N; Antoniou C; Kalogeromitros D; Theoharides TC
    Br J Dermatol; 2012 Jun; 166(6):1349-52. PubMed ID: 22283733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing hormone-receptor 2 is required for acute stress-induced bladder vascular permeability and release of vascular endothelial growth factor.
    Boucher W; Kempuraj D; Michaelian M; Theoharides TC
    BJU Int; 2010 Nov; 106(9):1394-9. PubMed ID: 20201838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMC-1 human mast cells synthesize neurotensin (NT) precursor, secrete bioactive NT-like peptide(s) and express NT receptor NTS1.
    Cochrane DE; Carraway RE; Harrington K; Laudano M; Rawlings S; Feldberg RS
    Inflamm Res; 2011 Dec; 60(12):1139-51. PubMed ID: 21927981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotensin serum levels and skin gene expression are increased in atopic dermatitis.
    Vasiadi M; Mondolfi AP; Alysandratos KD; Therianou A; Katsarou-Katsari A; Petrakopoulou T; Theoharidis A; Miniati A; Theoharides TC
    Br J Dermatol; 2013 Sep; 169(3):695-9. PubMed ID: 24033157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of urocortin in rat lung and its effect on pulmonary vascular permeability.
    Wu Y; Xu Y; Zhou H; Tao J; Li S
    J Endocrinol; 2006 Apr; 189(1):167-78. PubMed ID: 16614391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells.
    Asadi S; Alysandratos KD; Angelidou A; Miniati A; Sismanopoulos N; Vasiadi M; Zhang B; Kalogeromitros D; Theoharides TC
    J Invest Dermatol; 2012 Feb; 132(2):324-9. PubMed ID: 22089831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotensin stimulation of mast cell secretion is receptor-mediated, pertussis-toxin sensitive and requires activation of phospholipase C.
    Barrocas AM; Cochrane DE; Carraway RE; Feldberg RS
    Immunopharmacology; 1999 Feb; 41(2):131-7. PubMed ID: 10102794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in Apolipoprotein E knockout mice.
    Huang M; Pang X; Karalis K; Theoharides TC
    Cardiovasc Res; 2003 Jul; 59(1):241-9. PubMed ID: 12829195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis.
    Piliponsky AM; Chen CC; Nishimura T; Metz M; Rios EJ; Dobner PR; Wada E; Wada K; Zacharias S; Mohanasundaram UM; Faix JD; Abrink M; Pejler G; Pearl RG; Tsai M; Galli SJ
    Nat Med; 2008 Apr; 14(4):392-8. PubMed ID: 18376408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotensin enhances plasma adrenocorticotropin concentration by stimulating corticotropin-releasing hormone secretion.
    Nussdorfer GG; Malendowicz LK; Meneghelli V; Mazzocchi G
    Life Sci; 1992; 50(9):639-43. PubMed ID: 1311050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.